Author Correction: CPSF3-dependent pre-mRNA processing as a druggable node in AML and Ewing's sarcoma.
-
Ross NT
Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
-
Lohmann F
Novartis Institutes for BioMedical Research, Basel, Switzerland.
-
Carbonneau S
Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
-
Fazal A
Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
-
Weihofen WA
Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
-
Gleim S
Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
-
Salcius M
Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
-
Sigoillot F
Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
-
Henault M
Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
-
Carl SH
Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
-
Rodríguez-Molina JB
Medical Research Council Laboratory of Molecular Biology, Cambridge, UK.
-
Miller HR
Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
-
Brittain SM
Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
-
Murphy J
Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
-
Zambrowski M
Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
-
Boynton G
Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
-
Wang Y
Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
-
Chen A
Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
-
Molind GJ
Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
-
Wilbertz JH
Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
-
Artus-Revel CG
Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
-
Jia M
Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
-
Akinjiyan FA
Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
-
Turner J
Novartis Institutes for BioMedical Research, Basel, Switzerland.
-
Knehr J
Novartis Institutes for BioMedical Research, Basel, Switzerland.
-
Carbone W
Novartis Institutes for BioMedical Research, Basel, Switzerland.
-
Schuierer S
Novartis Institutes for BioMedical Research, Basel, Switzerland.
-
Reece-Hoyes JS
Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
-
Xie K
Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
-
Saran C
Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
-
Williams ET
Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
-
Roma G
Novartis Institutes for BioMedical Research, Basel, Switzerland.
-
Spencer M
Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
-
Jenkins J
Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
-
George EL
Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
-
Thomas JR
Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
-
Michaud G
Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
-
Schirle M
Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
-
Tallarico J
Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
-
Passmore LA
Medical Research Council Laboratory of Molecular Biology, Cambridge, UK.
-
Chao JA
Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
-
Beckwith REJ
Novartis Institutes for BioMedical Research, Cambridge, MA, USA. rohan.beckwith@novartis.com.
Show more…
Published in:
- Nature chemical biology. - 2020
English
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
-
Language
-
-
Open access status
-
bronze
-
Identifiers
-
-
Persistent URL
-
https://sonar.ch/global/documents/93577
Statistics
Document views: 63
File downloads: